Based on the Human Microbiomes market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Human Microbiomes market covered in Chapter 5:
Enterome Bioscience
Pharma PLC
UBiome
Synlogic
LNC Therapeutics
Evelo Biosciences
Second Genome
Ferring Pharmaceuticals
Seres Therapeutics
E.I. du Pont de Nemours and Company (DuPont)
ViThera Pharmaceuticals
BiomX
Vedanta Biosciences
In Chapter 6, on the basis of types, the Human Microbiomes market from 2015 to 2025 is primarily split into:
Prebiotic
Probiotic
Food
Medical Food
Drug
In Chapter 7, on the basis of applications, the Human Microbiomes market from 2015 to 2025 covers:
Therapeutics
Diagnostics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Human Microbiomes Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Enterome Bioscience
5.1.1 Enterome Bioscience Company Profile
5.1.2 Enterome Bioscience Business Overview
5.1.3 Enterome Bioscience Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Enterome Bioscience Human Microbiomes Products Introduction
5.2 Pharma PLC
5.2.1 Pharma PLC Company Profile
5.2.2 Pharma PLC Business Overview
5.2.3 Pharma PLC Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Pharma PLC Human Microbiomes Products Introduction
5.3 UBiome
5.3.1 UBiome Company Profile
5.3.2 UBiome Business Overview
5.3.3 UBiome Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 UBiome Human Microbiomes Products Introduction
5.4 Synlogic
5.4.1 Synlogic Company Profile
5.4.2 Synlogic Business Overview
5.4.3 Synlogic Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Synlogic Human Microbiomes Products Introduction
5.5 LNC Therapeutics
5.5.1 LNC Therapeutics Company Profile
5.5.2 LNC Therapeutics Business Overview
5.5.3 LNC Therapeutics Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 LNC Therapeutics Human Microbiomes Products Introduction
5.6 Evelo Biosciences
5.6.1 Evelo Biosciences Company Profile
5.6.2 Evelo Biosciences Business Overview
5.6.3 Evelo Biosciences Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Evelo Biosciences Human Microbiomes Products Introduction
5.7 Second Genome
5.7.1 Second Genome Company Profile
5.7.2 Second Genome Business Overview
5.7.3 Second Genome Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Second Genome Human Microbiomes Products Introduction
5.8 Ferring Pharmaceuticals
5.8.1 Ferring Pharmaceuticals Company Profile
5.8.2 Ferring Pharmaceuticals Business Overview
5.8.3 Ferring Pharmaceuticals Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Ferring Pharmaceuticals Human Microbiomes Products Introduction
5.9 Seres Therapeutics
5.9.1 Seres Therapeutics Company Profile
5.9.2 Seres Therapeutics Business Overview
5.9.3 Seres Therapeutics Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Seres Therapeutics Human Microbiomes Products Introduction
5.10 E.I. du Pont de Nemours and Company (DuPont)
5.10.1 E.I. du Pont de Nemours and Company (DuPont) Company Profile
5.10.2 E.I. du Pont de Nemours and Company (DuPont) Business Overview
5.10.3 E.I. du Pont de Nemours and Company (DuPont) Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 E.I. du Pont de Nemours and Company (DuPont) Human Microbiomes Products Introduction
5.11 ViThera Pharmaceuticals
5.11.1 ViThera Pharmaceuticals Company Profile
5.11.2 ViThera Pharmaceuticals Business Overview
5.11.3 ViThera Pharmaceuticals Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 ViThera Pharmaceuticals Human Microbiomes Products Introduction
5.12 BiomX
5.12.1 BiomX Company Profile
5.12.2 BiomX Business Overview
5.12.3 BiomX Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 BiomX Human Microbiomes Products Introduction
5.13 Vedanta Biosciences
5.13.1 Vedanta Biosciences Company Profile
5.13.2 Vedanta Biosciences Business Overview
5.13.3 Vedanta Biosciences Human Microbiomes Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Vedanta Biosciences Human Microbiomes Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Human Microbiomes Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Human Microbiomes Sales and Market Share by Types (2015-2020)
6.1.2 Global Human Microbiomes Revenue and Market Share by Types (2015-2020)
6.1.3 Global Human Microbiomes Price by Types (2015-2020)
6.2 Global Human Microbiomes Market Forecast by Types (2020-2025)
6.2.1 Global Human Microbiomes Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Human Microbiomes Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Human Microbiomes Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Human Microbiomes Sales, Price and Growth Rate of Prebiotic
6.3.2 Global Human Microbiomes Sales, Price and Growth Rate of Probiotic
6.3.3 Global Human Microbiomes Sales, Price and Growth Rate of Food
6.3.4 Global Human Microbiomes Sales, Price and Growth Rate of Medical Food
6.3.5 Global Human Microbiomes Sales, Price and Growth Rate of Drug
6.4 Global Human Microbiomes Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Prebiotic Market Revenue and Sales Forecast (2020-2025)
6.4.2 Probiotic Market Revenue and Sales Forecast (2020-2025)
6.4.3 Food Market Revenue and Sales Forecast (2020-2025)
6.4.4 Medical Food Market Revenue and Sales Forecast (2020-2025)
6.4.5 Drug Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Human Microbiomes Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Human Microbiomes Sales and Market Share by Applications (2015-2020)
7.1.2 Global Human Microbiomes Revenue and Market Share by Applications (2015-2020)
7.2 Global Human Microbiomes Market Forecast by Applications (2020-2025)
7.2.1 Global Human Microbiomes Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Human Microbiomes Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Human Microbiomes Revenue, Sales and Growth Rate of Therapeutics (2015-2020)
7.3.2 Global Human Microbiomes Revenue, Sales and Growth Rate of Diagnostics (2015-2020)
7.4 Global Human Microbiomes Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Therapeutics Market Revenue and Sales Forecast (2020-2025)
7.4.2 Diagnostics Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Human Microbiomes Sales by Regions (2015-2020)
8.2 Global Human Microbiomes Market Revenue by Regions (2015-2020)
8.3 Global Human Microbiomes Market Forecast by Regions (2020-2025)
9 North America Human Microbiomes Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Human Microbiomes Market Sales and Growth Rate (2015-2020)
9.3 North America Human Microbiomes Market Revenue and Growth Rate (2015-2020)
9.4 North America Human Microbiomes Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Human Microbiomes Market Analysis by Country
9.6.1 U.S. Human Microbiomes Sales and Growth Rate
9.6.2 Canada Human Microbiomes Sales and Growth Rate
9.6.3 Mexico Human Microbiomes Sales and Growth Rate
10 Europe Human Microbiomes Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Human Microbiomes Market Sales and Growth Rate (2015-2020)
10.3 Europe Human Microbiomes Market Revenue and Growth Rate (2015-2020)
10.4 Europe Human Microbiomes Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Human Microbiomes Market Analysis by Country
10.6.1 Germany Human Microbiomes Sales and Growth Rate
10.6.2 United Kingdom Human Microbiomes Sales and Growth Rate
10.6.3 France Human Microbiomes Sales and Growth Rate
10.6.4 Italy Human Microbiomes Sales and Growth Rate
10.6.5 Spain Human Microbiomes Sales and Growth Rate
10.6.6 Russia Human Microbiomes Sales and Growth Rate
11 Asia-Pacific Human Microbiomes Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Human Microbiomes Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Human Microbiomes Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Human Microbiomes Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Human Microbiomes Market Analysis by Country
11.6.1 China Human Microbiomes Sales and Growth Rate
11.6.2 Japan Human Microbiomes Sales and Growth Rate
11.6.3 South Korea Human Microbiomes Sales and Growth Rate
11.6.4 Australia Human Microbiomes Sales and Growth Rate
11.6.5 India Human Microbiomes Sales and Growth Rate
12 South America Human Microbiomes Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Human Microbiomes Market Sales and Growth Rate (2015-2020)
12.3 South America Human Microbiomes Market Revenue and Growth Rate (2015-2020)
12.4 South America Human Microbiomes Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Human Microbiomes Market Analysis by Country
12.6.1 Brazil Human Microbiomes Sales and Growth Rate
12.6.2 Argentina Human Microbiomes Sales and Growth Rate
12.6.3 Columbia Human Microbiomes Sales and Growth Rate
13 Middle East and Africa Human Microbiomes Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Human Microbiomes Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Human Microbiomes Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Human Microbiomes Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Human Microbiomes Market Analysis by Country
13.6.1 UAE Human Microbiomes Sales and Growth Rate
13.6.2 Egypt Human Microbiomes Sales and Growth Rate
13.6.3 South Africa Human Microbiomes Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Human Microbiomes Market Size and Growth Rate 2015-2025
Table Human Microbiomes Key Market Segments
Figure Global Human Microbiomes Market Revenue ($) Segment by Type from 2015-2020
Figure Global Human Microbiomes Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Human Microbiomes
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Enterome Bioscience Company Profile
Table Enterome Bioscience Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Enterome Bioscience Production and Growth Rate
Summary: Get latest Market Research Reports on Human Microbiomes. Industry analysis & Market Report on Human Microbiomes is a syndicated market report, published as Global Human Microbiomes Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Human Microbiomes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.